Spreadsheet: 4ee4a9d3-d65b-4729-9d89-c615ff41060c
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
BDIAL | Test | BDIAL | Bleeding Diathesis Profile, Limited | Bleeding Diath Prof, Limited | PTC/6599, PTMX/9053, APTTB/6548, APTTM/9118, TT/9059, FXIII/9068, RPTL/9078, DVRT/80340, DRVTM/32467, DRVTC/32468, STLA/82756: Clot-Based Assay F_2/9121, FACTV/9054, F_7/9055, F_10/9066, F2_IS/7806, F5_IS/7808, F7_IS/7810, 10_IS/7812: Prothrombin Time Clot-Based Assay F8A/9070, F_9/9065, F_11/9067, F_12/9069, F9_IS/7802, 11_IS/7804: Activated Partial Thromboplastin Time-Based Clotting Assay PNP/8866: Activated Partial Thromboplastin Time (APTT) Mixing Test RIST/9046: Ristocetin Induced Agglutination of Washed Normal Platelets VWAG/9051, DIRM/6625: Automated Latex Immunoassay (LIA) SFM/6600: Immunoturbidimetric FIBC/80343: Clauss Methodology APSM/9084: Amidolysis of Chromogenic Substrate VWFM/31046: Agarose Gel Electrophoresis/Infrared Dye-Labeled Antibody Detection VWFX/89792: Latex Particle Enhanced Immunoassay IBETH/7288, F8IS/7289: Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 5 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vials [NAME]: 5 mL in 5 plastic vials each containing 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again. 2. Freeze specimens immediately at < or =-40 degrees C, if possible. 3. Send specimens in the same shipping container. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient should not be receiving [NAME] or heparin. 3. If priority specimen, mark request form, give reason, and request a call-back. Forms: Coagulation Patient Information Sheet (Supply T675) | Internal:  Two 4.5 mL 3.2% Sodiu | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | An interpretive report will be provided. | Monday through Friday | Varies | 7 days, 21 days if multimers ordered |  |  |  |  |  |  | Rochester
BDIAL | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
BDIAL | Component | PTC | Prothrombin Time (PT), Plasma | Prothrombin Time (PT), P | Clot-Based Assay | Varies: Var |  |  | 5 | Varies | Only orderable as part of a coagulation consultation. |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject |  |  | 1 day | 5 days | 1 | 85610 |  |  | Yes | Yes (order PT)
PTC | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
PTC | Result | PR_TI | Prothrombin Time (PT), P | Prothrombin Time (PT), P | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | 5902-2
PTC | Result | INR2 | INR | INR | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6301-6
BDIAL | Component | APTTB | Activated Partial Thromboplastin Time (APTT), Plasma | Activated Partial Thrombopl Time, P | Clot-Based Assay | Varies: Var |  |  |  | Varies | Only orderable as part of a coagulation consultation. |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze & note to lab Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | 26-36 seconds The normal full-term newborn APTT may be up to 35% longer than in adults and even longer (up to twice the adult upper limit) in healthy premature infants. Typically, the APTT is in the adult reference range by age 3 months in healthy full-term infants and by age 6 months in healthy premature infants (30-60 weeks gestation.)   See Pediatric Hemostasis References | Monday through Friday | 2 hours | 4 days | 1 | 85730 |  |  | Yes | Yes (order APT)
APTTB | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
APTTB | Result | APTTB | Activated Partial Thrombopl Time, P | Activated Partial Thrombopl Time, P | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | 14979-9
BDIAL | Component | TT | Thrombin Time (Bovine), Plasma | Thrombin Time (Bovine), P | Clot-Based Assay Measures time of fibrinogen to fibrin conversion after adding bovine thrombin | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | Varies | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL  Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze and note to lab Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | 15-23 seconds | Monday through Friday | 2 hours | 4 days | 1 | 85670 |  |  | Yes | Yes
TT | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
TT | Result | TT | Thrombin Time (Bovine), P | Thrombin Time (Bovine), P | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | 46717-5
BDIAL | Component | DIRM | D-Dimer, Plasma | D-Dimer, P | [NAME] | Light blue-top 3.2% Sodium Citrate tube(s): BluNaCi |  |  | 1 | mL |  |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze & note to lab Lipemia	Mild OK; Gross reject Icteric	NA | < or =250 ng/ml D-Dimer Units (DDU) < or = 0.5 ug/mL Fibrinogen Equivalent Units (FEU) | Monday through Friday; p.m. | 1 hour | 4 days | 1 | 85379 |  |  | Yes | Yes (order DDI)
DIRM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DIRM | Result | DDMDR | Fibrinogen Equivalent Units (FEU) | Fibrinogen Equivalent Units (FEU) | Numeric |  |  |  |  | mcg/mL FEU |  |  |  |  |  |  |  |  |  | In Process
DIRM | Result | DDIME | D-Dimer Units (DDU) | D-Dimer Units (DDU) | Numeric |  |  |  |  | ng/mL D-Dimer |  |  |  |  |  |  |  |  |  | In Process
BDIAL | Component | SFM | Soluble [NAME] | Soluble [NAME] | Only orderable as part of a profile. For further information see: THRMP/83093 Thrombophilia Profile OR BDIAL/83094 Bleeding Diathesis Profile, Limited OR PROCT/83097 Prolonged Clot Time Profile  Internal Only: BDIAC/83095 Bleeding Diathesis Profile, Comprehensive OR DCICF/83098 DIC/ICF Profile | Light blue-top 3.2% Sodium Citrate tube(s): BluNaCi |  |  | 1 | mL | Only orderable as part of a profile. For further information see: THRMP/83093 Thrombophilia Profile OR BDIAL/83094 Bleeding Diathesis Profile, Limited OR PROCT/83097 Prolonged Clot Time Profile |  | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold refreeze - note to lab Lipemia	Yes Icterus	NA Other	NA | Only orderable as part of a profile. For further information see: THRMP/83093 Thrombophilia Profile OR BDIAL/83094 Bleeding Diathesis Profile, Limited OR PROCT/83097 Prolonged Clot Time Profile OR  Internal Only BDIAC/83095 Bleeding Diathesis Profile, Comprehensive OR DCICF/83098 DIC/ICF Profile | Monday through Friday | 1 hour | 4 days | 1 | 85366 |  |  | Yes | No
SFM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
SFM | Result | SFM | Soluble [NAME] | Soluble [NAME] | Numeric |  |  |  |  | mcg/mL |  |  |  |  |  |  |  |  |  | 40702-3
BDIAL | Component | FIBC | Fibrinogen, Plasma | Fibrinogen, P | Clauss; Thrombin Clotting Rate Assay | Light blue-top 3.2% Sodium Citrate tube(s): BluNaCi AND |  |  |  | Varies |  |  | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icterus	NA Other	NA | Males: 200-375 mg/dL Females: 200-430 mg/dL  Full-term infants and premature (30-36 weeks gestation) newborn infants: fibrinogen is near adult levels (>150 mg/dl) and reaches adult levels by < or =21 days postnatal. | Monday through Friday | 1 day | 2 days | 1 | 85384 |  |  | Yes | Yes (order FIB)
FIBC | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
FIBC | Result | FIBC | Fibrinogen, P | Fibrinogen, P | Numeric |  |  |  |  | mg/dL |  |  |  |  |  |  |  |  |  | 3255-7
BDIAL | Component | F8A | Coagulation Factor VIII Activity Assay, Plasma | Coag Factor VIII Activity Assay, P | Activated Partial Thromboplastin Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Not offered for detection of hemophilia carrier. 6. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason, we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 55-200% Normal, full-term newborn infants or healthy premature infants usually have normal or elevated factor [NAME].* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85240 |  |  | Yes | Yes
F8A | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F8A | Result | F8A | Coag Factor VIII Activity Assay, P | Coag Factor VIII Activity Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3209-4
BDIAL | Component | VWAG | von Willebrand Factor [NAME], Plasma | von Willebrand Factor Ag, P | Automated Latex Immunoassay (LIA) | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. 3. Tests for VWFX/89792 von Willebrand Factor Activity, Plasma and F8A/9070 Coagulation Factor VIII Activity Assay, Plasma are recommended in conjunction with [NAME] antigen. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icterus	NA Other	NA | 55-200% Note: Individuals of blood group "O" may have lower plasma von Willebrand factor (VWF) antigen than those of other ABO blood groups, such that apparently normal individuals of blood group "O" may have plasma VWF antigen as low as 40% to 50%, whereas the lower limit of the reference range for individuals of other blood groups may be 60% to 70%. Children: [NAME], infants, and children have normal or mildly increased plasma VWF antigen, with respect to the adult reference range. | Monday through Saturday | 1 day | 3 days | 1 | 85246 |  |  | Yes | Yes
VWAG | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
VWAG | Result | VWAG | von Willebrand Factor Ag, P | von Willebrand Factor Ag, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 27816-8
BDIAL | Component | VWFX | von Willebrand Factor Activity, Plasma | von Willebrand Factor Activity, P | Latex Particle Enhanced Immunoassay |  |  |  | 1 | mL | See Coagulation Studies in Special Instructions.    Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 2 mL in 2 plastic vials each containing 1 mL Collection Instructions: 1. Specimen must be drawn prior to factor replacement therapy. 2. Spin down, remove plasma, and spin plasma again. 3. Freeze specimens immediately at < or =-40 degrees C, if possible. 4. Send specimens in the same shipping container. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. 3. Tests for F8A/9070 Coagulation Factor VIII Activity Assay, [NAME] and [NAME], Plasma are recommended in conjunction with [NAME] activity. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK refreeze - note to lab Lipemia	Mild OK; Gross reject Icterus	NA Other	NA | 55-200%   Normal, full-term newborn infants may have mildly increased levels which reach adult levels by 90 days postnatal. Healthy, premature infants (30-36 weeks gestation) may have increased levels that reach adult levels by 180 days. Note: Individuals of blood group "O" may have lower plasma von Willebrand factor (VWF) activity than those of other ABO blood groups, such that apparently normal individuals of blood group "O" may have plasma VWF activity as low as 40% to 50%, whereas the lower limit of the reference range for individuals of other blood groups may be 60% to 70%. | Monday through Saturday | 1 day | 3 days | 1 | 85397 |  |  | Yes | Yes
VWFX | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
VWFX | Result | VWFX | von Willebrand Factor Activity, P | von Willebrand Factor Activity, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 68324-3
VWFX | [NAME] | RIST | [NAME], Plasma | [NAME], P | Ristocetin Induced Agglutination of Washed Normal Platelets | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (sodium citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions:  1. Fasting. 2. Spin down, remove plasma, and spin plasma again. 3. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information:  1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. 3. Tests for F8A/9070 Coagulation Factor VIII Activity Assay, [NAME] and [NAME], Plasma are recommended in conjunction with ristocetin cofactor. 4. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason, we suggest ordering VWPR/83099 von Willebrand Profile. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK-refreeze-note to lab Lipemia	Mild OK; Gross reject Icterus	NA Other	NA | Adults: 55-200% Note: Individuals of blood group "O" may have lower plasma von Willebrand factor (VWF) ristocetin cofactor activity than those of other ABO blood groups, such that apparently normal individuals of blood group "O" may have plasma VWF ristocetin cofactor activity as low as 40% to 50%, whereas the lower limit of the reference range for individuals of other blood groups may be 60% to 70%.   Normal, full-term newborn infants or healthy premature infants usually have levels in the adult range. | Monday through Friday; p.m. | 1 day | 7 days | 1 | 85245 |  |  | No | No
RIST | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
RIST | Result | 9046 | [NAME], P | [NAME], P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 6014-5
BDIAL | Component | FXIII | Factor [NAME] (13), Screen | Factor XIII(13),Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	NA | Normal | Monday through Friday; p.m. | 3 hours | 4 days | 1 | 85291 |  |  | Yes | No
FXIII | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
FXIII | Result | 9068 | Factor XIII(13),Scrn | Factor XIII(13),Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
BDIAL | Component | CCC | Special Coagulation Interpretation | Special Coagulation Interpretation | Interpretive reports on tests performed in Mayo's Special Coag Lab. |  |  |  |  |  |  |  |  |  | Monday through Friday; Varies |  |  | 1 | 85390 |  |  | Yes | No
CCC | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
CCC | Result | 7525 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 69049-5
CCC | Result | 7769 | Reviewed by: | Reviewed by: | Alphanumeric
BDIAL | [NAME] | IBETH | Bethesda Units | Bethesda Units | Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 3 | mL |  |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | 0 unit | Monday through Friday | 2 days | 5 days | 1 | 85335 |  |  | No | No
IBETH | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
IBETH | Result | 7288 | Bethesda Units | Bethesda Units | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13591-3
BDIAL | [NAME] | F8IS | Coagulation Factor VIII Inhibitor Screen, Plasma | Coag Factor VIII Assay [NAME],P | Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 3 | mL | See "Coagulation Studies" in Special Instructions   1.  Draw blood in light blue-top (citrate) tube(s). Spin down, remove plasma, spin plasma again, and place 3 mL of citrate 	platelet-poor plasma into 3 plastic vials each containing 1 mL. 	([NAME] vial is not acceptable.) 	Note:		A.	[NAME] must be collected prior to factor replacement therapy. B.   Double-centrifuged specimens are critical for accurate results as platelet contamination may 	cause spurious results. 2.	Freeze specimens immediately at < or = -40 degrees C, if possible. 3.	Send specimens frozen in shipping container. 	Note:		Each coagulation assay requested should have its own separate patient vial. 4.	If priority specimen, mark requisition, give reason, and request a call-back. Note:	If ordering electronically, no form is required with the specimen. If not ordering electronically, please complete 		and submit a "Coagulation Request Form" (Supply T237) with the specimen. | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative If positive, quantitated in Bethesda units. | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
F8IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F8IS | Result | 7289 | Coag Factor VIII Assay [NAME],P | Coag Factor VIII Assay [NAME],P | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3206-0
BDIAL | [NAME] | RIST | [NAME], Plasma | [NAME], P | Ristocetin Induced Agglutination of Washed Normal Platelets | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (sodium citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions:  1. Fasting. 2. Spin down, remove plasma, and spin plasma again. 3. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information:  1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. 3. Tests for F8A/9070 Coagulation Factor VIII Activity Assay, [NAME] and [NAME], Plasma are recommended in conjunction with ristocetin cofactor. 4. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason, we suggest ordering VWPR/83099 von Willebrand Profile. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK-refreeze-note to lab Lipemia	Mild OK; Gross reject Icterus	NA Other	NA | Adults: 55-200% Note: Individuals of blood group "O" may have lower plasma von Willebrand factor (VWF) ristocetin cofactor activity than those of other ABO blood groups, such that apparently normal individuals of blood group "O" may have plasma VWF ristocetin cofactor activity as low as 40% to 50%, whereas the lower limit of the reference range for individuals of other blood groups may be 60% to 70%.   Normal, full-term newborn infants or healthy premature infants usually have levels in the adult range. | Monday through Friday; p.m. | 1 day | 7 days | 1 | 85245 |  |  | No | No
RIST | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
RIST | Result | 9046 | [NAME], P | [NAME], P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 6014-5
BDIAL | [NAME] | FACTV | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | [NAME] Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 70-165% Normal, full-term newborn infants may have borderline low or mildly decreased levels (> or =30% to 35%) which reach adult levels within 21 days postnatal. Healthy premature infants (30-36 weeks gestation) may have borderline low or mildly decreased levels.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 2 days | 1 | 85220 |  |  | No | Yes
FACTV | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
FACTV | Result | FACTV | Coag Factor V Assay, P | Coag Factor V Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3193-0
BDIAL | [NAME] | F_7 | Coagulation Factor VII Activity Assay, Plasma | Coag Factor VII Assay, P | [NAME] Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 65-180% Normal, full-term newborn infants or healthy premature infants may have decreased levels (> or =20%) which increase within the first postnatal week but may not reach adult levels for > or =180 days postnatal.*  *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85230 |  |  | No | Yes
F_7 | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F_7 | Result | F_7 | Coag Factor VII Assay, P | Coag Factor VII Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3198-9
BDIAL | [NAME] | F_9 | Coagulation Factor IX Activity Assay, Plasma | Coag Factor IX Assay, P | Activated Partial Thromboplastin Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 65-140% Normal, full-term newborn infants or healthy premature infants may have decreased levels (> or =20%) which may not reach adult levels for > or =180 days postnatal.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85250 |  |  | No | Yes
F_9 | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F_9 | Result | F_9 | Coag Factor IX Assay, P | Coag Factor IX Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3187-2
BDIAL | [NAME] | F_10 | Coagulation Factor X Activity Assay, Plasma | Coag Factor X Assay, P | [NAME] Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. 3. If priority specimen, mark request form, give reason, and request a call-back. 4. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 70-150% Normal, full-term newborn infants or healthy premature infants may have decreased levels (> or =15-20%) which may not reach adult levels for > or =180 days postnatal.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85260 |  |  | No | Yes
F_10 | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F_10 | Result | F_10 | Coag Factor X Assay, P | Coag Factor X Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3218-5
BDIAL | [NAME] | F_11 | Coagulation Factor XI Activity Assay, Plasma | Coag Factor XI Assay, P | Activated Partial Thromboplastin Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 55-150% Normal, full-term newborn infants or healthy premature infants may have decreased levels (> or =10%) which may not reach adult levels for > or =180 days postnatal.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85270 |  |  | No | Yes
F_11 | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F_11 | Result | F_11 | Coag Factor XI Assay, P | Coag Factor XI Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3226-8
BDIAL | [NAME] | F_12 | Coagulation Factor XII Activity Assay, Plasma | Coag Factor XII Assay, P | Activated Partial Thromboplastin Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 55-180% Normal, full-term newborn infants or healthy premature infants may have decreased levels (> or =15% to 20%) which may not reach adult levels for > or =180 days postnatal.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85280 |  |  | No | Yes
F_12 | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F_12 | Result | F_12 | Coag Factor XII Assay, P | Coag Factor XII Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3232-6
BDIAL | [NAME] | RPTL | Reptilase Time, Plasma | Reptilase Time, P | Clot-Based Assay Measures conversion of fibrinogen to fibrin clot after addition of reptilase. | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | Varies | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial Specimen Volume: For single orders, 1 mL. If ordering a profile, refer to specific Coagulation Profile ordered. Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | 14-23 seconds | Monday through Friday | 1 hour | 4 days | 1 | 85635 |  |  | No | Yes
RPTL | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
RPTL | Result | RPTL | Reptilase Time, P | Reptilase Time, P | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | 6683-7
BDIAL | [NAME] | APSM | [NAME], Plasma | [NAME], P | Hydrolysis of Synthetic Chromogenic Substrate, Colorimetric End point Includes measurement of the function of antiplasmin, mostly alpha-2-antiplasmin, with slight interference from alpha-2-macroglobulin. | Light blue-top (citrate) tube: LgtBlu |  |  | 0.5 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Each coagulation assay requested should have its own vial. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK-refreeze-note to lab Lipemia	Mild OK; Gross reject Icterus	NA Other	NA | Adults: 80-140% Normal, full-term newborn infants may have borderline low or mildly decreased levels (> or =50%) which reach adult levels within 5 to 7 days postnatal.* Healthy, premature infants (30-36 weeks gestation) may have mildly decreased levels which reach adult levels in < or =90 days postnatal.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday; Varies | 1 day | 7 days | 1 | 85410 |  |  | No | Yes
APSM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
APSM | Result | APSM | [NAME], P | [NAME], P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 27810-1
BDIAL | [NAME] | F_2 | Coagulation Factor II Activity Assay, Plasma | Coag Factor II Assay, P | [NAME] Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 75-145% Normal, full-term newborn infants or healthy premature infants may have decreased levels (> or =25%) which may remain below adult levels for > or =180 days postnatal.*  *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 3 days | 1 | 85210 |  |  | No | Yes
F_2 | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F_2 | Result | F_2 | Coag Factor II Assay, P | Coag Factor II Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3289-6
BDIAL | [NAME] | DRVT | [NAME] Viper Venom Time (DRVVT), Plasma | Dilute Russells Viper Venom Time, P | Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL |  |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | DRVVT Screen Ratio = <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. | Monday through Friday | 1 day | 4 days | 1 | 85613 |  |  | No | No
DRVT | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DRVT | Result | RVVR | DRVVT Screen Ratio | DRVVT Screen Ratio | Numeric |  |  |  |  | ratio |  |  |  |  |  |  |  |  |  | 15359-3
DRVT | [NAME] | DRVTM | DRVVT Mix | DRVVT Mix | Clot-Based Assay | Varies: Var |  |  |  |  | Only orderable as part of a coagulation consultation. |  |  | <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. |  | 2 days | 5 days | 1 | 85613 |  |  | No | No
DRVTM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DRVTM | Result | RVVMX | DRVVT Mix Ratio | DRVVT Mix Ratio | Numeric |  |  |  |  | ratio |  |  |  |  |  |  |  |  |  | In Process
DRVTM | [NAME] | DRVTC | DRVVT Confirmation | DRVVT Confirmation | Clot-Based Assay | Varies: Var |  |  |  |  | Only orderable as part of a coagulation consultation. |  |  | <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. |  | 2 days | 5 days | 1 | 85613 |  |  | No | No
DRVT | [NAME] | DRVTC | DRVVT Confirmation | DRVVT Confirmation | Clot-Based Assay | Varies: Var |  |  |  |  | Only orderable as part of a coagulation consultation. |  |  | <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. |  | 2 days | 5 days | 1 | 85613 |  |  | No | No
DRVTC | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DRVTC | Result | CRVV | DRVVT [NAME] | DRVVT [NAME] | Numeric |  |  |  |  | ratio |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | F9_IS | Factor IX Inhibitor Screen | Factor IX Inhib Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
F9_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F9_IS | Result | 7802 | Factor IX Inhib Scrn | Factor IX Inhib Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30086-3
BDIAL | [NAME] | 11_IS | Factor XI Inhibitor Screen | Factor [NAME] Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
11_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
11_IS | Result | 7804 | Factor [NAME] Scrn | Factor [NAME] Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | F2_IS | Factor II Inhibitor Screen | Factor II Inhib Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
F2_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F2_IS | Result | 7806 | Factor II Inhib Scrn | Factor II Inhib Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | F5_IS | Factor V Inhibitor Screen | Factor V Inhib Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
F5_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F5_IS | Result | 7808 | Factor V Inhib Scrn | Factor V Inhib Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | F7_IS | Factor VII Inhibitor Screen | Factor [NAME] | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
F7_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F7_IS | Result | 7810 | Factor [NAME] | Factor [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | 10_IS | Factor X Inhibitor Screen | Factor X Inhib Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | No | No
10_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
10_IS | Result | 7812 | Factor X Inhib Scrn | Factor X Inhib Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 39556-6
BDIAL | [NAME] | PNP | Platelet Neutralization Procedure | Platelet Neutralization Procedure | Activated Partial Thormboplastin Time (APTT) Mixing Test | Varies: Var |  |  |  | Varies |  |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | An interpretive report will be provided | Monday through Friday | 2 hours | 4 days | 1 | 85597 |  |  | No | No
PNP | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
PNP | Result | PNPPL | Platelet Neutralization Procedure | Platelet Neutralization Procedure | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 40647-0
PNP | Result | PNPSA | PNP Buffer Control | PNP Buffer Control | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | PTMX | PT Mix 1:1 | PT Mix 1:1 | Clot-Based Assay | Varies: Var |  |  |  | Varies | Only available as part of a coagulation consultation. |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject |  | Monday through Friday | 1 day | 4 days | 1 | 85611 |  |  | No | No
PTMX | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
PTMX | Result | PTMX | PT Mix 1:1 | PT Mix 1:1 | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | 5959-2
BDIAL | [NAME] | APTTM | APTT Mix 1:1 | APTT Mix 1:1 | Clot-Based Assay | Varies: Var |  |  |  | mL | Available only as part of a coagulation consultation. |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject |  | Monday through Friday | 2 hours | 4 days | 1 | 85732 |  |  | No | No
APTTM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
APTTM | Result | APTTM | APTT Mix 1:1 | APTT Mix 1:1 | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | 5946-9
BDIAL | [NAME] | DRVTM | DRVVT Mix | DRVVT Mix | Clot-Based Assay | Varies: Var |  |  |  |  | Only orderable as part of a coagulation consultation. |  |  | <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. |  | 2 days | 5 days | 1 | 85613 |  |  | No | No
DRVTM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DRVTM | Result | RVVMX | DRVVT Mix Ratio | DRVVT Mix Ratio | Numeric |  |  |  |  | ratio |  |  |  |  |  |  |  |  |  | In Process
DRVTM | [NAME] | DRVTC | DRVVT Confirmation | DRVVT Confirmation | Clot-Based Assay | Varies: Var |  |  |  |  | Only orderable as part of a coagulation consultation. |  |  | <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. |  | 2 days | 5 days | 1 | 85613 |  |  | No | No
DRVTC | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DRVTC | Result | CRVV | DRVVT [NAME] | DRVVT [NAME] | Numeric |  |  |  |  | ratio |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | DRVTC | DRVVT Confirmation | DRVVT Confirmation | Clot-Based Assay | Varies: Var |  |  |  |  | Only orderable as part of a coagulation consultation. |  |  | <1.2 Normal ranges for Children: Not clearly established, but similar to normal ranges for adults, except for newborn infants whose results may not reach adult values until 3-6 months of age. |  | 2 days | 5 days | 1 | 85613 |  |  | No | No
DRVTC | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
DRVTC | Result | CRVV | DRVVT [NAME] | DRVVT [NAME] | Numeric |  |  |  |  | ratio |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | STLA | Staclot Lupus Anticoagulant, Plasma | Staclot LA, P | Clot-Based Assay | Varies: Var |  |  | 5 | mL | Only available as part of a coagulation consultation |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze - note to lab Lipemia	Mild OK; Gross reject Icteric	NA | Staclot delta: 0-7 seconds | Monday through Friday | Same day/1 day | 3 days | 1 | 85598 |  |  | No | No
STLA | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
STLA | Result | SAPTT | Staclot APTT | Staclot APTT | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 14979-9
STLA | Result | DELTA | Staclot Delta | Staclot Delta | Numeric |  |  |  |  | sec |  |  |  |  |  |  |  |  |  | In Process
BDIAL | [NAME] | VWFM | von WillebrandFactor Multimer Analysis, Plasma | von Willebrand Factor Multimer, P | Agarose Gel Electrophoresis/Infrared Dye-Labeled Antibody Detection |  |  |  | 0.5 | mL | Only orderable as part of a coagulation consultation. | 0.5 mL | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold OK - refreeze & note to lab Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | An interpretive report will be provided. | Monday, Tuesday | 7 days | 10 days | 1 | 85247 |  |  | No | Yes (order 8844)
VWFM | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
VWFM | Result | 31046 | von Willebrand Factor Multimer, P | von Willebrand Factor Multimer, P | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 32217-2